Sarepta Therapeutics (SRPT) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.47% |
| Dec 31, 2025 | -10.37% |
| Sep 30, 2025 | 27.52% |
| Jun 30, 2025 | 24.92% |
| Mar 31, 2025 | -82.06% |
| Dec 31, 2024 | 20.32% |
| Sep 30, 2024 | 17.14% |
| Jun 30, 2024 | 15.08% |
| Mar 31, 2024 | 18.69% |
| Dec 31, 2023 | 18.84% |
| Sep 30, 2023 | 16.74% |
| Jun 30, 2023 | 30.54% |
| Mar 31, 2023 | -60.51% |
| Dec 31, 2022 | -27.36% |
| Sep 30, 2022 | -30.39% |
| Jun 30, 2022 | -18.17% |
| Mar 31, 2022 | -22.73% |
| Dec 31, 2021 | 2.46% |
| Sep 30, 2021 | 12.65% |
| Jun 30, 2021 | 5.45% |
| Mar 31, 2021 | -9.90% |
| Dec 31, 2020 | -10.76% |
| Sep 30, 2020 | -14.87% |
| Jun 30, 2020 | -13.83% |
| Mar 31, 2020 | 31.18% |
| Dec 31, 2019 | -23.95% |
| Sep 30, 2019 | -19.08% |
| Jun 30, 2019 | -34.49% |
| Mar 31, 2019 | -7.37% |
| Dec 31, 2018 | -54.88% |
| Sep 30, 2018 | 1.50% |
| Jun 30, 2018 | -22.72% |
| Mar 31, 2018 | 16.06% |
| Dec 31, 2017 | 30.97% |
| Sep 30, 2017 | 18.51% |
| Jun 30, 2017 | -39.03% |
| Mar 31, 2017 | 31.70% |
| Dec 31, 2016 | -93.32% |
| Sep 30, 2016 | -45.65% |
| Jun 30, 2016 | -89.60% |
| Mar 31, 2016 | -72.11% |
| Dec 31, 2015 | 1.08% |
| Sep 30, 2015 | -77.98% |
| Jun 30, 2015 | -46.44% |